Literature DB >> 8518898

Results of a prospective randomized trial of the Angelchik prosthesis and of a consecutive series of 119 patients.

I A Eyre-Brook1, B W Codling, M W Gear.   

Abstract

The results of a randomized multicentre trial comparing the Angelchik prosthesis with floppy Nissen fundoplication for gastro-oesophageal reflux were assessed 4-6 years after surgery. Of the original 52 patients 48 were traced. A good or excellent result (Visick grade 1 or 2) was obtained in 21 of 25 after insertion of the Angelchik prosthesis compared with 18 of 23 after fundoplication. Poor results were due to recurrent heartburn after fundoplication and to dysphagia after prosthesis insertion. In a separate consecutive series of 119 patients receiving Angelchik prostheses, results were good or excellent in 101 (85 per cent) and poor in 18 (15 per cent). Control of reflux with a correctly positioned prosthesis was good. Troublesome dysphagia (Visick grade 3 or 4) was experienced in eight of the 119 patients. There was no mortality and no incidence of splenectomy or gas-bloat syndrome.

Entities:  

Mesh:

Year:  1993        PMID: 8518898     DOI: 10.1002/bjs.1800800517

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  4 in total

1.  [Conventional and minimally invasive surgical methods for gastroesophageal reflux].

Authors:  K-H Fuchs
Journal:  Chirurg       Date:  2005-04       Impact factor: 0.955

Review 2.  Surgical treatment of gastroesophageal reflux disease.

Authors:  Christian A Gutschow; Arnulf H Hölscher
Journal:  Langenbecks Arch Surg       Date:  2012-04-12       Impact factor: 3.445

3.  Esophagogastric Fistula Caused by an Angelchik Antireflux Prosthesis.

Authors:  Mark M Pence; Mark Hubbard; Manish B Singla; Patrick E Young
Journal:  ACG Case Rep J       Date:  2015-07-09

Review 4.  Magnetic challenge against gastroesophageal reflux.

Authors:  Mauro Bortolotti
Journal:  World J Gastroenterol       Date:  2021-12-28       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.